SPEAKERS

The World Health Summit brings together leading researchers, physicians, government officials, and representatives from industry and civil society worldwide. Speakers at the World Health Summit 2020 include:

Marylyn Martina Addo

Marylyn Martina Addo

Head of Infectious Disease at the University Medical Center Hamburg-Eppendorf, Germany

Marylyn Martina Addo is a German virologist who is a Professor and the German Center for Infection Research (DZIF) Head of Infectious Disease at the University Medical Center Hamburg-Eppendorf. Addo has developed and tested vaccinations that protect people from Ebola virus disease and the MERS coronavirus EMC/2012. She is currently developing a viral vector based COVID-19 vaccine. Addo studied medicine at the University of Bonn. She earned her diploma at the London School of Hygiene and Tropical Medicine, during which she researched Candida albicans transmission between HIV-positive people. In 1999 she moved to Boston, where she specialised in infectious diseases at the Harvard Medical School. In 2013 Addo returned to Germany, where she was made a Professor and the German Center for Infection Research (DZIF) Head of Infectious Disease at the University Medical Center Hamburg-Eppendorf.

Tedros Adhanom Ghebreyesus

Tedros Adhanom Ghebreyesus

Director-General, World Health Organization

Dr. Tedros Adhanom Ghebreyesus has been Director-General of the World Health Organization since 2017. Upon assuming office, he outlined five key priorities for the WHO: universal health coverage; health emergencies; women’s, children’s and adolescents’ health; health impacts of climate and environmental change; and a transformed WHO. Tedros is globally recognized as a health scholar, researcher, and diplomat with first-hand experience in research, operations, and leadership in emergency responses to epidemics. He previously served as Ethiopia’s Minister of Foreign Affairs, Ethiopia’s Minister of Health, and Chair of the Board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria.  

Peter Albiez

Peter Albiez

CEO, Pfizer Germany

Peter Albiez is the Country Manager of Pfizer Germany. After joining Pfizer in 1996, he held positions of increasing responsibility within sales and marketing. In 2009, Peter was appointed Head of Primary Care and joined the Pfizer Germany Executive Management Board. In March 2015, he was named Country Manager of Pfizer Germany. Peter is actively engaged in professional organizations whose goals reflect his personal beliefs of advancing healthcare and supporting cultural exchange. He is an Advisory Board Member and Cluster Speaker of HealthCapital Berlin-Brandenburg and Chairman of the Regional Board Berlin/Brandenburg of the Association for the Promotion of Humanities and Sciences in Germany. In addition, he is Chairman of the Board of the Society of Friends of the Max Delbrueck Center for Molecular Medicine (MDC). Peter holds a Master of Science in Biology.

John Amuasi

John Amuasi

Co-Chair, Lancet Commission on One Health, Ghana

Dr. Amuasi is faculty at the Global Health Department of the School of Public Health, KNUST and also Group Leader of the Global Health and Infectious Diseases Research Group at the Kumasi Center for Collaborative Research in Tropical Medicine which hosts the Secretariat of the African Research Network for Neglected Tropical Diseases (ARNTD) of which he is the Executive Director. Dr. Amuasi trained as a physician at the KNUST School of Medical Sciences, and later graduated from the University of Minnesota School of Public Health, USA, with post-graduate degrees terminating in a PhD in Health Research and Policy. He also served as head of the R&D Unit at the 1,000-bed Komfo Anokye teaching Hospital in Kumasi, Ghana for 3 years from 2007-2010. Dr. Amuasi’s is passionate about research that focuses on improving health systems, services and outcomes, including policy analyses using both primary and secondary data in low and middle-income countries. His research currently involves field epidemiologic studies on cryptosporidiosis, malaria, and some neglected tropical diseases. Dr Amuasi is also at the fore-front of global efforts towards addressing emerging and reemerging infectious diseases and serves as an Executive Committee member of the African Coalition for Epidemic Research, Response and Training (ALERRT).

Niels Annen

Niels Annen

Minister of State, Federal Foreign Office, Federal Republic of Germany

Niels Annen is a German politician and Minister of State at the Federal Foreign Office. Prior to this, he served as spokesperson on foreign affairs of the SPD Parliamentary Group in the German Bundestag. 2010, Annen joined the German Marshall Fund as a Senior Fellow in Washington, D.C.. Between 2011 and 2013, he served as director of European policy analysis at the Berlin headquarters of the Friedrich Ebert Foundation. Annen holds a bachelor's degree in history from the Humboldt University of Berlin and a master's degree in International Public Policy from the Paul H. Nitze School of Advanced International Studies at Johns Hopkins University in Washington, D.C..

Photo: Hila Azadzoy

Hila Azadzoy

Managing Director, Global Health Initiatives, Ada Health GmbH, Germany

Hila Azadzoy is an accomplished social entrepreneur dedicated to using the power of technology for social good. In 2018, Hila joined Ada Health to lead its Global Health Initiative, which is focused on improving the availability and delivery of primary care to underserved populations worldwide. Prior to Ada, Hila was a Founding Member and Head of Academics of Kiron Open Higher Education, an award-winning social startup working to remove the barriers to higher education for refugees worldwide through smart digital solutions. Hila is a recipient of the Digital Female Leader Award, an MIT Solver and a frequent public speaker, having spoken at international forums such as TEDx, Clinton Global Initiative, UNESCO NGO Forum, UBS Social Innovator and World Summit AI.

Michelle Bachelet

Michelle Bachelet

United Nations High Commissioner for Human Rights

Michelle Bachelet Jeria assumed her functions as United Nations High Commissioner for Human Rights on September 1, 2018. She is the seventh Commissioner to hold the office, which was established in 1993. Bachelet was previously President of Chile (2006-2010 and 2014-2018), and was the country's first female president. She also served as Chile's Health Minister (2000-2002) an was Latin America’s first female Defense Minister (2002-2004). Prior to her appointment as High Commissioner for Human Rights, Bachelet held a number of UN positions in the areas of women's rights and maternal, newborn, and child health. She has a Medical Degree in surgery, with a specialization in pediatrics and public health. 

Manica Balasegaram

Manica Balasegaram

Executive Director, GARDP, Switzerland

Dr. Manica Balasegaram is GARDP’s Executive Director and has been instrumental in leading GARDP through its three-year incubation to an independent legal entity, during which time GARDP launched four programmes and built a skilled and dedicated team with expertise from a range of sectors and backgrounds. Manica trained as a medical doctor at the University of Nottingham, UK from where he started his career in internal and emergency medicine. From 2001 onwards, he worked as a doctor and researcher in several countries in Sub- Saharan Africa and Southern Asia. He also gained significant experience working in humanitarian emergencies and responses, largely with Médecins Sans Frontières (MSF). At the end of 2007 he joined the Drugs for Neglected Diseases initiative as Head of Leishmaniasis Clinical Program – a position he held for four years before returning to MSF as Executive Director of their Access Campaign. He was appointed Director of GARDP in June 2016. He is also currently a board member of the Medicines Patent Pool as well as of FIND’s Scientific Advisory Committee. Manica’s experience spans clinical and public health practice in infectious diseases and international work on health policy & access to medicines. He has served on numerous technical and health policy panels and expert groups. He also has substantial experience in conducting and overseeing clinical trials and drug development projects.

Photo: Ricardo Baptista Leite

Ricardo Baptista Leite

Member of Portuguese Parliament, Portugal

Ricardo Baptista Leite MP, MD is a Medical Doctor (ID-trained), member of Portuguese Parliament (Health and Foreign Affairs Committees) and National Spokesperson for Health of Social Democratic Party. He is the President of ‘UNITE – Parliamentarians Network to End HIV/AIDS, Viral Hepatitis and Other Infectious Diseases’; a global platform of parliamentarians committed to ending HIV/AIDS, viral hepatitis and other infectious diseases as global health threats by 2030. He is one of six people acknowledged globally by ‘The Economist’ as a ‘HCV Change Maker’ and is the Head of Public Health at Católica University of Portugal, Coordinator of Sustainable Healthcare at NOVA Information Management School and Guest Lecturer at NOVA Medical School. He has also served as the former Deputy Mayor of the city of Cascais.

Winnie Byanyima

Winnie Byanyima

Executive Director, Joint United Nations Programme on HIV and AIDS (UNAIDS)

Winnie Byanyima assumed her functions as Executive Director of UNAIDS since 2019.
Prior to that, she has been the Executive Director of Oxfam International and served as the Director of Gender and Development at the United Nations Development Programme.
Ms Byanyima began her career as a champion of marginalized communities and women 30 years ago as a member of parliament in the National Assembly of Uganda. In 2004, she became the Director of Women and Development at the African Union Commission, working on the Protocol on the Rights of Women in Africa, an international human rights instrument that became an important tool for reducing the disproportionate effect of HIV on the lives of women in Africa.
She holds an advanced degree in mechanical engineering (in energy conservation and the environment) from the Cranfield Institute of Technology and an undergraduate degree in aeronautical engineering from the University of Manchester.

Thomas B. Cueni

Thomas B. Cueni

Director General, IFPMA, Switzerland

Thomas B. Cueni is Director General of IFPMA since 1 February 2017. Prior to joining IFPMA he was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland. For many years Thomas Cueni has been involved in the work of the European Federation of Pharmaceutical Industries and Associations, EFPIA, where he most recently served as Vice-Chair of the European Markets Committee and association representative on the Board. He represented the industry on the EU High Level Pharmaceutical Forum, was Chairman of EFPIA’s Economic and Social Policy Committee and Chairman of the EFPIA Task Force on the EU Commission’s Pharmaceutical Sector Inquiry. Thomas Cueni also represented Interpharma, which he successfully transformed from the association of Swiss Rx companies to the association of pharmaceutical research companies in Switzerland, on the Council of IFPMA. Prior to his appointment with Interpharma, Thomas Cueni had a career as a journalist.

Roopa Dhatt

Roopa Dhatt

Executive Director and Co-Founder, Women in Global Health, USA

Dr. Roopa Dhatt is a physician by training and an advocate by principle, striving for greater health and well-being for all people through working in global health. She is the Executive Director and co-founder of Women in Global Health, a movement that strives to bring greater gender equality to global health leadership. Since its foundation Women in Global Health, an organization staffed entirely by volunteers, has expanded to become a global movement, with chapters in four continents and more than 21,000 followers in 90+ countries.

Christian Drosten

Christian Drosten

Director, Institute of Virology, Charité - Universitätsmedizin Berlin, Germany

Christian Drosten is the Director of the Institute of Virology of the Charité - Universitätsmedizin Berlin. This year he has become an internationally respected COVID-19 expert. In 2003 he discovered the unknown virus causing SARS and developed a diagnostic test that enabled public health authorities worldwide to stop a beginning pandemic. Drosten has co-authored more than 300 peer-reviewed papers and coordinated research consortia funded by the European Union, Deutsche Forschungsgemeinschaft, and the German Ministry of Research. He is a member of the internal advisory board of the German Center for Infection Research (DZIF) and the speaker of the German National Research Network for Zoonotic Infections. He received the German Federal Cross of Merit for his work to counter the SARS epidemic.

Victor Dzau

Victor Dzau

President, National Academy of Medicine, USA

Prof. Dr. Victor Dzau is the President of the National Academy of Medicine (NAM). In addition, he serves as Vice Chair of the National Research Council. He is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Previously, Dr. Dzau was the Hersey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital, as well as Chairman of the Department of Medicine and Director of the Falk Cardiovascular Research Center at Stanford University. His pioneering research in the field of cardiovascular medicine and genetics has made significant impact on medicine and health.

Henrietta H. Fore

Henrietta H. Fore

Executive Director, UNICEF

Henrietta H. Fore has been UNICEF’s Executive Director since 2018. She has worked to champion economic development, education, health, humanitarian assistance and disaster relief in a public service, private sector and non-profit leadership career that spans more than four decades. She has previously served as Administrator for USAID and Director of United States Foreign Assistance, Undersecretary of State for Management at the US Department of State, Director of the United States Mint in the US Department of Treasury, and Chair of the Board and Chief Executive Officer of Holsman International, a manufacturing and investment company.

Tom Frieden

Tom Frieden

President and CEO, Resolve to Save Lives, USA

Dr. Frieden is a physician trained in internal medicine, infectious diseases, public health, and epidemiology.  He began his public health career in New York City confronting the largest outbreak of multi-drug resistant tuberculosis to occur in the US.  He was then assigned to India, on loan from the Centers for Disease Control and Prevention, where he helped scale up a program for effective tuberculosis diagnosis, treatment, and monitoring.  Asked to return to New York City to become Mayor Mike Bloomberg’s Health Commissioner, he directed efforts to reduce smoking and other leading causes of death that increased life expectancy by 3 years.  As Director of the US Centers for Disease Control and Prevention, Dr. Frieden oversaw the work that helped end the 2014 West Africa Ebola epidemic.  Dr. Tom Frieden now leads Resolve to Save Lives, a $225 million, 5-year initiative of Vital Strategies, which aims to save millions of lives from cardiovascular disease and make the world safer from epidemics.

Tomaž Gantar

Minister of Health, Slovenia

Tomaž Gantar, born on 21 March 1960, graduated from the Faculty of Medicine in Ljubljana in 1987 and specialised in urology in 1994. Through his many years of work in healthcare he obtained expertise and experience in the organization, operation, financing and management of the healthcare system. He has attended numerous professional meetings in Slovenia and abroad. He was the managing director of the Izola General Hospital from 1999 to 2004 and the mayor of the Municipality of Piran from 2006 to 2010. Mr Gantar was a member and chair of several supervisory boards and institute councils. He was the Minister of Health in 2012 and 2013 and a deputy of the National Assembly of the Republic of Slovenia in the 2014–2018 term. During that time, he was also the chair of the Committee on Health of the National Assembly. Afterwards, he worked as a specialist doctor and head of the urology department at the Izola General Hospital.

George F. Gao

George F. Gao

Director, Chinese Center for Disease Control and Prevention, China

George F. Gao is a Chinese virologist and immunologist. He has served as Director of the Chinese Center for Disease Control and Prevention since 2017 and Dean of the Savaid Medical School of the University of Chinese Academy of Sciences since 2015. Gao is an academician of the Chinese Academy of Sciences and The World Academy of Sciences, as well as a foreign associate of the US National Academy of Sciences and the US National Academy of Medicine. He was awarded the TWAS Prize in Medical Science in 2012 and the Nikkei Asia Prize in 2014.

Stefan Germann

Stefan Germann

CEO, Fondation Botnar, Switzerland

Dr. Stefan Germann is the CEO of Fondation Botnar, which works to improve the health and wellbeing of children and young people in growing secondary cities, connecting diverse partners and investing in solutions that leverage AI and digital innovation. Germann was previously Executive Director of onegoalglobal.org, an innovative collaborative child nutrition and healthy lifestyle campaign, and Senior Director of the World Vision International Sustainable Health Partnership, Innovation and Accountability unit based in Kuala Lumpur, Malaysia. He has also held several board and advisory board memberships.

Lawrence O. Gostin

Lawrence O. Gostin

Director, O’Neill Institute for National and Global Health Law (WHO Collaborating Center), Georgetown University, USA

Lawrence O. Gostin is University Professor, Georgetown University’s highest academic rank, and Founding O’Neill Chair in Global Health Law. He directs the World Health Organization Center on National and Global Health Law. Gostin is Professor of Medicine at Georgetown University and Professor of Public Health at Johns Hopkins University. The WHO Director-General appointed Prof. Gostin to high-level positions, including expert panels on the International Health Regulations (IHR) and on Mental Health. He served on the Director-General’s Advisory Committee on Reforming WHO, as well as WHO expert advisory committees on pandemic influenza, smallpox, genomic sequencing, and migrant health. He served on WHO’s Blue Ribbon Panel on global health equity. He co-chairs the Lancet Commission of Global Health Law

Rafael Mariano Grossi

Director General, International Atomic Energy Agency (IAEA)

IAEA Director General Rafael Mariano Grossi assumed office on 3 December 2019. Mr Grossi is a diplomat with over 35 years of experience in the field of non-proliferation and disarmament. In 2013, he was appointed Ambassador of Argentina to Austria and Argentinian  Representative to the IAEA and other Vienna-based International Organizations. In  2019, Mr Grossi acted as President Designate of the 2020 Review Conference of the Parties to the Treaty on the Non-Proliferation of Nuclear Weapons (NPT), and from 2014 to 2016 he served as president of the Nuclear Suppliers Group, where he was  the first president to serve two successive terms. In 2015, he presided over the Diplomatic Conference of the Convention on  Nuclear Safety, securing unanimous approval for the Vienna Declaration on Nuclear Safety – a milestone in international efforts in the wake of the 2011 FukushimaDaiichi nuclear accident.

 

Andrew Haines

Sir Andrew Haines

Professor, Environmental Change and Public Health, London School of Hygiene & Tropical Medicine, UK

Sir Andrew Haines is Professor of Environmental Change and Public Health at LSHTM, with a joint appointment in the Department of Public Health, Environments, and Society and in the Department of Population Health. He was previously Director (originally Dean) of LSHTM for nearly 10 years, and before that Professor of Primary Health Care at University College London. He worked part-time as a general practitioner in North London for many years and has been a member of a number of major international and national committees. Haines was knighted in 2005 for his services to medicine.

Richard J. Hatchett

Richard Hatchett

CEO, Coalition for Epidemic Preparedness Innovations (CEPI)

Richard J. Hatchett, MD, is Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership of public, private, philanthropic and civil organizations that finances and co-ordinates the development of vaccines against emerging infectious diseases with pandemic or epidemic potential. Prior to joining CEPI, Dr. Hatchett served as the U.S. Biomedical Advanced Research and Development Authority’s (BARDA) Chief Medical Officer and Deputy Director. Following this he became acting Director of BARDA. Previously, Dr. Hatchett served on the Homeland Security Council under President George W. Bush and was a member of the National Security Staff under President Barack Obama.

Gerald Haug

Gerald Haug

President, German National Academy of Sciences Leopoldina, Germany

Gerald Haug is the President of the Deutsche Akademie der Naturforscher Leopoldina – German National Academy of Sciences, Halle (Saale) since 2020. He is a paleoclimatologist, marine geologist and paleoceanographer and Professor for Climate Geochemistry, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland. He studies the development of the Earth climate over thousands to millions of years. He analyses sediment cores from the sea floor and lakes, amongst several other climate archives. The chemical composition of the different sediment layers provides clues to the prevailing climatic conditions at the time of deposition. This allows quantitative reconstructions of past climate conditions and the underlying processes in the ocean, atmosphere and climate system. 

Paul Hudson

Paul Hudson

CEO, Sanofi, France

Paul Hudson joined Sanofi as CEO on September 1, 2019. Previously CEO of Novartis Pharmaceuticals (2016-2019), where he was a member of the Executive Committee, Paul has an expansive international career in healthcare that spans the U.S., Japan and Europe. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and most recently carried out the roles of president, AstraZeneca United States and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synthélabo U.K. Paul holds a degree in economics from Manchester Metropolitan University in the U.K. and last year his alma mater awarded him an honorary Doctor of Business Administration for his achievements in industry. He also holds a diploma in marketing from the Chartered Institute of Marketing, also in the U.K.

Rachel Huxley

Rachel Huxley

Director, Knowledge & Learning, C40, UK

Dr. Rachel Huxley is Director of Knowledge and Learning, responsible for C40’s knowledge management strategy and research program. Rachel has been with C40 for over 4 years during which time she has developed and led a priority program of research on the multiple benefits of urban climate action and overseen the launch of C40’s flagship Knowledge Hub. Prior to this Rachel was Chief Executive of Peterborough Environment City Trust, leading the Trust’s work on sustainable behavior change and engagement project delivery, as well as, working strategically with city partners to develop a sustainable city plan.  As part of her work on sustainable cities Rachel established and led the Sustainable Cities Network, an informal network of leading UK cities to enable sharing of best practice and challenges. Rachel has a PhD from the University of Leeds on the processes and practices of sustainable transition and decision making in cities. 

Jayasree Iyer

Jayasree Iyer

Executive Director, Access to Medicine Foundation, Netherlands

Dr. Jayasree K. Iyer leads the Access to Medicine Foundation as Executive Director, directing strategy, stakeholder dialogues, and research programs. As a spokesperson, she is actively involved in stimulating change within the pharmaceutical industry. She has worked at the interface of the global health community and the pharmaceutical industry for 12 years. Before joining the Foundation, Iyer was responsible for creating, negotiating, and managing public private partnerships in R&D for infectious diseases and oncology. She has worked at NGOs, academic institutions and think tanks.

Natalia Kanem

Natalia Kanem

Executive Director, United Nations Population Fund (UNFPA)

Dr. Natalia Kanem is the Executive Director of the United Nations Population Fund (UNFPA), the United Nations sexual and reproductive health and rights agency. Appointed by United Nations Secretary-General António Guterres in 2017, Dr. Kanem has more than 30 years of strategic leadership experience in the fields of preventive medicine, public and reproductive health, social justice and philanthropy. Dr. Kanem holds a medical degree from Columbia University in New York, and a Master’s degree in Public Health with specializations in epidemiology and preventive medicine from the University of Washington in Seattle. She is a magna cum laude graduate of Harvard University in history and science.

Given Katuta

Given Katuta

Member of Parliament & Head of IPU Advisory Group on Health, Zambia

Hon. Given Katuta is a Member of Parliament of the National Assembly of Zambia. She was elected to head the Inter Parliamentary Union IPU Advisory Group on Health in 2019. The Advisory Group's main focus is to end the HIV/AIDS epidemic and aims to significantly improve the health of women and children in different parts of the world. It is part of the overall commitment to health and to help achieve the UN Sustainable Development Goals.

Stefan Kaufmann

Stefan Kaufmann

Director Emeritus, Max Planck Institute for Infection Biology, Germany

After holding several positions including Staff Scientist at the Max Planck Institute for Immunobiology in Freiburg and Chair of the Department of Immunology at the University of Ulm, he became the Founding Director of the Max Planck Institute for Infection Biology in Berlin. Since 2019 he is Director Emeritus at this institute. The Microbiology and Immunology expert is a member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) and the German National Academy of Sciences Leopoldina.

Ilona Kickbusch

Ilona Kickbusch

International Advisory Board Chair, Global Health Centre, Graduate Institute Geneva, Switzerland

Prof. Ilona Kickbusch’s work focuses on the political determinants of health, health in all policies, and global health. She established the Global Health Centre at the Graduate Institute and served as its director until 2019. She advises countries on global health strategies and trains health specialists and diplomats in global health diplomacy. Among other positions, Kickbusch is a member of the Global Preparedness Monitoring Board and the WHO High-Level Independent Commission on NCDS and is co-chair of UHC 2030. She acts as Council Chair to the World Health Summit in Berlin. She has had a distinguished career with the WHO and chairs the international advisory board for the development of the German global health strategy.

Donna Kinnair

Donna Kinnair

Chief Executive and General Secretary, Royal College of Nursing, United Kingdom

Professor Dame Donna Kinnair is a British nurse and has been Chief Executive and General Secretary of the Royal College of Nursing since August 2018. She has specialised in child protection, providing leadership in major hospital trusts in London, teaching, and advising on legal and governmental committees. Kinnair has had several senior positions in the healthcare sector. She has also taught medical law, ethics and child protection in multiple countries including Britain, New Zealand, Russia and Kenya. In addition, she has provided advice to the UK government on nursing and midwifery through her work with the prime minister's commission in 2010. Kinnair was appointed Head of Nursing of the Royal College of Nursing in 2015 after which she was promoted to Director for Nursing, Policy and Practice in 2016. In August 2018 she was appointed acting Chief Executive and General Secretary before being confirmed on a permanent basis in April 2019.

Depei Liu

Depei Liu

Co-Chair, InterAcademy Partnership (IAP) for Health, China

Professor Depei Liu's central research interests are medical molecular biology and research in gene regulation. He executes various prestigious positions, including former President of the Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC).

Bernardo Mariano

Bernardo Mariano Jr.

Chief Information Officer, World Health Organization

Bernardo Mariano Junior is the Chief Information Officer at the World Health Organization. In this role, he is responsible for coordinating WHO’s digital health vision and strategy. He leads and oversees all aspects of information technology, data security, and enterprise applications, ensuring WHO is advancing its digital capabilities to deliver its global health goals effectively.

Director Africa Centres for Disease Control and Prevention

John Nkengasong

Director Africa Centres for Disease Control and Prevention

Dr. John Nkengasong is Director of the African Centres for Disease Control and Prevention. Until recently he was the Associate Director for Laboratory Science and Chief of the International Laboratory Branch at the Division of HIV & TB, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Atlanta. In addition, Dr. Nkengasong co-chairs the US President’s Emergency Plan for AIDS Relief’s (PEPFAR) Laboratory Technical Working Group and serves as the founding chair of Board of Directors for the African Society for Laboratory Medicine.

Carlos Nobre

Carlos Nobre

Director, Center for Earth System Science, Brazil

Carlos A. Nobre is an Earth System scientist from Brazil. He graduated in Electronics Engineering from the Aeronautics Institute of Technology (ITA), Brazil, in 1974 and obtained a PhD in Meteorology from the Massachusetts Institute of Technology (MIT), USA, in 1983. He dedicated his scientific carrier mostly to Amazonian and climate science at Brazil’s National Institute of Amazonian Research (INPA) and National Institute of Space Research (INPE). He is a former National Secretary of R&D of Ministry of Science and Technology of Brazil and former President of the Federal Agency for Post-Graduate Education-CAPES. He is foreign member of the US National Academy of Sciences, member of the Brazilian Academy of Science and of the World Academy of Science. He was awarded the Volvo Environmental Prize in 2016, the Von Humboldt Medal of EGU in 2010 and was one of the authors of IPCC AR4 awarded with the Nobel Peace Prize in 2007.

Tolullah Oni

Tolullah Oni

Clinical Senior Research Associate, MRC Epidemiology Unit, University of Cambridge, UK

Tolullah Oni is a Public Health Physician Scientist and urban epidemiologist, a Clinical Senior Research Associate and joint lead of the Global Public Health at the University of Cambridge MRC Epidemiology Unit, and Honorary Associate Professor in Public Health at the University of Cape Town. Born in Lagos, she completed her medical training at University College London, postgraduate medical training in the UK and Australia, a Masters degree in Public Health (Epidemiology) at the University of Cape Town, and a research doctorate in Clinical Epidemiology at Imperial College London. She leads the Research Initiative for Cities Health and Equity (RICHE) conducting transdisciplinary urban health research generating evidence to support development and implementation of healthy public policies in rapidly growing cities, with a focus on Africa. She serves on several advisory boards including Future Earth and the African Academy of Science Open Research Platform; and is an editorial board member of Lancet Planetary Health, Cities and Health, and the Journal of Urban Health. Profiled in the Lancet (2016), Science magazine (2018), and the British Medical Journal (2019), she is a Fellow of the African Academy of Sciences, past co-chair of the Global Young Academy, 2015 Next Einstein Forum Fellow, and a 2019 World Economic Forum Young Global Leader.

Peter Piot

Peter Piot

Director, London School of Hygiene & Tropical Medicine, UK

Peter Piot was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations from 1995 until 2008, as well as the Associate Director of the WHO Global Programme on AIDS. He was a co-discoverer of the Ebola virus, and his research focuses upon HIV/AIDS, sexually transmitted infections, and women’s health.

Céline Pulcini

Céline Pulcini

National Project Manager for Antimicrobial Resistance, Ministry for Solidarity and Health, France

Dr. Céline Pulcini is a full professor of infectious disease in Nancy, France. Her main research interests lie in antimicrobial stewardship and vaccination practices with the aim of preventing the emergence of bacterial resistance to antibiotics. Prof. Pulcini is chair of ESGAP, the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Antimicrobial stewardship. She also serves as an expert for the National Antibiotic Plan as well as National Project Manager for Antimicrobial Resistance of the French Ministry of Health, for the European Centre for Disease Prevention and Control, and the World Health Organization.As well as serving as an associate editor for the journal Clinical Microbiology and Infection, Céline Pulcini has also authored or co-authored more than 180 international publications. In 2017, she received the ESCMID Young Investigator Award.

Michael Ryan

Michael Ryan

Executive Director, Health Emergencies Programme, World Health Organization

Dr. Mike Ryan has been at the forefront of managing acute risks to global health for nearly 25 years. He served as Assistant Director-General for Emergency Preparedness and Response in WHO's Health Emergencies Programme from 2017 to 2019. Dr. Ryan first joined WHO in 1996, with the newly established unit to respond to emerging and epidemic disease threats. He has worked in conflict affected countries and led many responses to high impact epidemics. He completed medical training at the National University of Ireland, Galway, a Master’s in Public Health at University College Dublin, and specialist training in communicable disease control at the Health Protection Agency in London and the European Programme for Intervention Epidemiology Training.

Stéphanie Seydoux

Stéphanie Seydoux

Ambassador for Global Health, France

Stéphanie Seydoux has been appointed French Ambassador for Global health in May 2018. She has served as the head of the Women’s Rights and Gender Equality Division, assistant to the Director General of Women’s Affairs and social cohesion from 2014 to 2017. Since November 2017, she was in charge of a support mission to the government for the revision of the bioethics law. After starting her career at the Ministry of Foreign Affairs, Stéphanie Seydoux joined the General Inspectorate of Social Affairs (IGAS) in 2004. From 2007 to 2010, she was head of the department for the promotion of equality at the High commission against discrimination and for equality (HALDE). From 2010 to 2013, she joined the Ministry of Foreign Affairs as first counsellor, deputy head of post at the French Embassy in Kenya.

Päivi Sillanaukee

Päivi Sillanaukee

Permanent Secretary, Ministry of Social Affairs and Health, Finland

Päivi Sillanaukee (MD, PhD, eMBA) is the Director-General of the Department of Wellbeing and Services of the Ministry of Social Affairs and Health of Finland. Dr Sillanaukee served as the Permanent Secretary of the Ministry in 2012 - 2019. Between 2008 and 2012, Dr Sillanaukee was the Director General of the Department for Social and Health Services at the Ministry. Previously, she was the Deputy Mayor and Director of Social and Health Services in the City of Tampere, Finland. Between 1990 and 2004, she held clinical and managerial positions in the Pirkanmaa Hospital District and was a member of the Tampere City Council. Dr Sillanaukee is a specialist in public health and management from the University of Helsinki. She has worked on policies to promote public health, social protection and gender equality in the European Union and global levels. She has represented Finland in the WHO Executive Board since May 2018 and is currently serving as its first Vice Chair. She is the co-chair of the Alliance for Health Security Cooperation (AHSC) and a member of the Steering Group of the Global Health Security Agenda.

Mariângela Simão

Mariângela Simão

Assistant Director-General, Access to Medicines and Health Products, World Health Organization

Mariângela Simão joined WHO in November 2017, as part of Dr Tedros Adhanom Ghebreyesus leadership team. She previously worked for UNAIDS since September 2010 and prior to that, she worked for the Ministry of Health in Brazil as the Director of the Sexually Transmitted Diseases, HIV/ AIDS and Viral Hepatitis department. She worked in the Brazilian public health system since 1982, from the primary health care level to a series of managerial positions throughout the years. As a public health professional, at municipal, state and national levels, she played an active role in the decentralization of the national health system, acquiring an extensive experience in health system strengthening. She has also served on the boards of a number of organizations and government committees related to public health and HIV. Heading the National Sexually Transmitted Diseases/HIV/AIDS Department (including Viral Hepatitis from 2009), she had the responsibility of overseeing and implementing the national Sexually Transmitted Diseases/AIDS/Viral Hepatitis policies, including universal and free of charge access to treatment, care and comprehensive prevention programs. Dr. Simão attended medical school in Brazil, with degrees in Paediatrics and Public Health, and a MSc in Mother and Child Health in the UK.

Photo: Dennis J. Snower

Dennis J. Snower

President, Global Solutions Initiative Foundation

Dennis J. Snower is President of the Global Solutions Initiative, which provides policy advice to the G20. He is Senior Research Fellow of the Blavatnik School of Governance, Oxford University; non-resident fellow of The Brookings Institution and visiting Professor at University College, London. Starting in September 2019, he will be Senior Professor at the Hertie School of Governance, Berlin. Furthermore, he is a Research Fellow at the Center for Economic Policy Research (London), at IZA (Institute for the Future of Work, Bonn), and CESifo (Munich). Dennis J. Snower was born in Vienna, Austria, where he went to the American International School. He earned a BA and MA from New College, Oxford University, and an MA and a PhD at Princeton University. He served most recently as President of the Kiel Institute for the World Economy, where he is now a president emeritus, and was previously Professor of Economics at Birkbeck College, University of London. 

Photo: Agnés Soucat

Agnés Soucat

Director for Health Systems, Governance and Financing, World Health Organization

Agnès Soucat is the Director for Health Systems Governance and Financing at the World Health Organization (WHO) in Geneva, Switzerland. Before joining WHO, she was Global Leader Service Delivery and Lead Economist at the World Bank. Dr. Soucat previously held the position of Director for Human Development for the African Development Bank, where she was responsible for health, education and social protection for 53 African countries. She has over 25 years of experience in health and poverty reduction, covering more than 70 countries in Africa, Asia and Europe. She was a pioneer of several innovations in health care financing including community-based financing and performance-based financing. She was commissioner of the recent Lancet and Rockefeller Commission on Planetary Health. Dr. Soucat holds an MD and a Masters in Nutrition from the University of Nancy in France as well as a Master of Public Health and PhD in Health Economics from the Johns Hopkins University.

Jens Spahn

Jens Spahn

Minister of Health, Germany

Jens Spahn is Germany’s Federal Minister of Health. He is a member of the German Bundestag and part of the center-right party Christian Democratic Union of Germany (CDU), which governs in partnership with the center-left Social Democratic Party of Germany (SPD). Spahn was party speaker for health policy from 2009-2015 and then served as Parliamentary State Secretary to the Federal Minister of Finance before becoming Minister of Health in March 2018.

Elhadj As Sy

Elhadj As Sy

Chair, Kofi Annan Foundation, Switzerland

Prior to his leadership role at the IFRC, Mr Sy was UNICEF’s Director of Partnerships and Resource Development in New York. He has also served as UNICEF Regional Director for Eastern and Southern Africa and Global Emergency Coordinator for the Horn of Africa. Mr Sy held leadership positions with the United Nations Development Programme in New York, with the Global Fund to fight AIDS, Tuberculosis and Malaria and with UNAIDS. Before joining the United Nations, Mr Sy served as Director of Health and Development Programmes with Environment and Development Action in the Third World in Dakar, Senegal. Mr Sy holds a Bachelor’s Degree in Arts and Human Sciences from the University of Dakar. He then pursued Master’s studies in Arts and Germanistik at the University of Graz and graduated from the Diplomatic Academy in Vienna. He was also awarded a postgraduate diploma in Education from the École normale supérieure in Dakar. He speaks English, French and German and is a national of Senegal.

Marta Temido

Marta Temido

Minister of Health, Portugal

Dr. Marta Temido has served as Portugal’s Minister of Health since 2018. She has also served as Chair of the Board of Portugual’s national health system and of several hospitals. Temido holds a PhD in International Health from Universidade Nova de Lisboa, as well as a law degree and master’s degree in health economics and management from the University of Coimbra. She has authored and co-authored several scientific publications on health topics.  

Marisol Touraine

Marisol Touraine

Chair of the Executive Board, Unitaid, Switzerland

Marisol Touraine is a French politician who served as Minister of Social Affairs and Health from 2012-2017, and was elected chair of the Executive Board of Unitaid in 2019. Ms. Touraine is a senior member of the Conseil d’État, France’s highest administrative court, and an international health and social welfare consultant.
In her ministerial post, she worked to improve HIV/AIDS prevention and early diagnosis, promoted universal hepatitis C treatment with innovative drugs, implemented plain tobacco packaging and launched a nutrition labelling system.

Effy Vayena

Effy Vayena

Chair of Bioethics, Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zurich, Switzerland

Dr. Effy Vayena is Professor of Bioethics at the Swiss Federal Institute of Technology Zürich (ETH Zürich). In her work, she investigates how advances in science can be ethically applied for best outcomes in public and personal health. Vayena completed her education as a social historian with a PhD in Medical History from the University of Minnesota and a habilitation on Bioethics and Health Policy at the University of Zurich. A keen interest in health policy led her to work for the World Health Organization where she served as a technical officer for several years. Upon her return to academia, Vayena was awarded a Swiss National Science Foundation professorship and founded the Health Ethics and Policy Lab. The lab’s purpose is to tackle ethical questions that arise at the cutting edge of biotech research, in areas such as genomic technologies and big data analytics for healthcare. The lab moved to ETH Zurich in 2017.

Ursula von der Leyen

Ursula von der Leyen

President, European Commission

Ursula von der Leyen is a German politician and has been the first female President of the European Commission since December 2019. She is a member of the Christian Democratic Union (CDU) and the European People's Party (EPP). She has previously served in the federal government of Germany as Federal Minister of Defence, Federal Minister of Labor and Social Affairs as well as Federal Minister for Family Affairs, Senior Citizens, Women and Youth.

Lothar H. Wieler

Lothar H. Wieler

President, Robert Koch Institute, Germany

Prof. Lothar H. Wieler is president of the Robert Koch Institute, the national public health institute in Germany. The Robert Koch Institute is in charge of health monitoring and surveillance, pandemic preparedness, and preventing and recognizing attacks with biological agents. Prof. Wieler's own research focus has been zoonoses, particularly on molecular mechanisms, enabling bacterial pathogens to infect different hosts, and develop antibiotic resistance. He is author/co-author of more than 220 peer-reviewed papers. Wieler is also deputy spokesperson of the intersectoral research consortium InfectControl 2020 and a member of the scientific advisory board of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), the WHO Europe Advisory Committee on Health Research (EACHR), and the WHO Strategic and Technical Advisory Group on Infectious Hazards (STEG-IH). Since 2010, he is an elected member of the German National Academy of Sciences.

Photo: John Eu-Li Wong

John Eu-Li Wong

Chief Executive Officer, National University Health System, Singapore

Dr John Eu-Li Wong, Isabel Chan Professor in Medical Sciences, is Senior Vice President (Health Affairs) at the National University of Singapore (NUS) and Chief Executive of the National University Health System (NUHS). A medical oncologist-haematologist, Dr Wong obtained his medical degree from NUS and did his residency and fellowship at the New York Hospital-Cornell Medical Center, where he was the Chief Resident in Medicine, and Memorial Sloan-Kettering Cancer Center. He is actively involved in the development of Health and Biomedical Sciences as a key pillar of Singapore's economy and serves as a member of the National Health and Biomedical Sciences Executive Committee. He is involved in the US National Academy of Medicine’s Planning Committee to develop ‘Global Roadmap for Healthy Longevity’, the Editorial Board of the Journal of the American Medical Association, the Association of Academic Health Centers - International, the M8 Alliance of Academic Health Centers where he was Past President of the World Health Summit in 2013, the Global Genomic Medicine Collaborative, the International Editorial Board of the American Journal of Medicine, and the Advisory Board to the Government of Qatar on Academic Medicine and Sidra Medicine.